NPS Pharmaceuticals, Inc.

Following its late 2019 merger with Aevi Genomic Medicine, Inc. , Cerecor Inc. is taking a new name – Avalo Therapeutics – and revising its therapeutic focus, having divested a pair of central nerv

Ayala Pharmaceuticals Inc. and Lyra Therapeutics Inc. said in US Securities and Exchange Commission (SEC) paperwork filed on the same day that they were gearing up to launch initial public offering

John Milligan is to stand down as CEO of Gilead Sciences Inc. at the end of the year. Former CEO and current chair John Martin will also stand down upon the appointment of a new CEO. Milligan

In taking the top job at the Massachusetts-based cancer specialty biotech ImmunoGen Inc. Mark Enyedy supplements his reputation as a top industry deal-maker with a new assignment: turnaround artist